| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:01 | Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word. | 2 | The Motley Fool | ||
| Sa | Where Will Madrigal Pharmaceuticals Be in 3 Years? | 2 | The Motley Fool | ||
| Mi | Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade | 4 | Investor's Business Daily | ||
| Mi | Madrigal Pharmaceuticals' Options Frenzy: What You Need to Know | 3 | Benzinga.com | ||
| 10.06. | Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals | 69 | The Motley Fool | ||
| 06.06. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra (resmetirom) Presented at the EASL Congress | 182 | GlobeNewswire (Europe) | Late-breaking AI-based analysis of MAESTRO-NASH biopsy data demonstrates Rezdiffra improved key fibrotic features that are predictive of progression to decompensated cirrhosisNoninvasive test data... ► Artikel lesen | |
| 05.06. | What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday? | 13 | Benzinga.com | ||
| 05.06. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | 12 | GlobeNewswire (USA) | ||
| 21.05. | Is Madrigal Pharmaceuticals Stock a Buy? | 13 | The Motley Fool | ||
| 08.05. | Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2024 Earnings Call Transcript | 16 | Insider Monkey | ||
| 07.05. | Madrigal Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary | 9 | Reuters | ||
| 07.05. | MADRIGAL PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
| 07.05. | MADRIGAL PHARMACEUTICALS, INC. - 8-K, Current Report | 8 | SEC Filings | ||
| 24.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Statement on the Passing of Dr. Stephen Harrison | 25 | GlobeNewswire (USA) | ||
| 16.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 194 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH)... ► Artikel lesen | |
| 05.04. | Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics | 37 | The Motley Fool | ||
| 03.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 88 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., April 03, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis... ► Artikel lesen | |
| 02.04. | MADRIGAL PHARMACEUTICALS, INC. - 8-K, Current Report | 8 | SEC Filings | ||
| 29.03. | Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals | 34 | The Motley Fool | ||
| 26.03. | Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock | 24 | The Motley Fool |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 416 |
| SNOWFLAKE | 297 |
| TUI | 256 |
| GAMESTOP | 250 |
| RHEINMETALL | 220 |
| EVOTEC | 179 |
| DEUTSCHE LUFTHANSA | 169 |
| NEL | 164 |
| BAYER | 155 |
| TESLA | 135 |
| BYD | 133 |
| VOLKSWAGEN | 104 |
| APPLE | 99 |
| BASF | 94 |
| PORSCHE SE | 90 |
| DEUTSCHE TELEKOM | 87 |
| THYSSENKRUPP | 83 |
| MERCEDES-BENZ | 82 |
| DEUTSCHE BANK | 76 |
| ALLIANZ | 68 |
| COMMERZBANK | 68 |
| AMAZON | 67 |
| PLUG POWER | 64 |
| RWE | 64 |
| BROADCOM | 63 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
